Status
Conditions
Treatments
About
Viral respiratory tract infections are very common in children. They contribute to missed time in school, work disruption for caregivers and can also cause severe illness requiring hospitalization and rarely death. In the 2022-2023, influenza, RSV and SARS-CoV-2 viruses infected a large number of children which strained the pediatric healthcare system in many jurisdictions. Unfortunately, there continues to be limited data on duration of infectiousness and transmission risk of these viruses to inform public health decisions during times when there is significant circulation of these viruses.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Viral dynamics (primary outcome):
Household testing inclusion criteria (secondary outcome):
-Any individual in the same household (i.e. household contacts, defined as residing at the same address) as the individual testing positive by PCR for influenza, RSV, SARS-CoV-2, mycoplasma pneumoniae, or bordetella pertussis
Classroom testing inclusion criteria (secondary outcome):
-Any individual in the same classroom (i.e. classroom contacts) as the individual testing positive by PCR for influenza, RSV, SARS-CoV-2, mycoplasma pneumoniae, or bordetella pertussis (i.e. case identified through the THS program)
Exclusion criteria
Viral dynamics (primary outcome):
-Participants will be ineligible if they are more than 5 days from symptom onset
Loading...
Central trial contact
Michelle Science; Aaron Campigotto
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal